A study showed an HPV prevalence of 15% in partners of those with HPV related oral cancer. (1)

ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, May 19, 2016 /EINPresswire.com/ --


“Infected with the human papillomavirus (HPV)? The CBCD recommends taking Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

A study showed that at least 15% of all sex partners of individuals with human papillomavirus (HPV) related oral cancers also have oral HPV infections. The study also found that uninfected sex partners have a much higher risk of becoming infected. As Dr. Tsao and colleagues wrote “Our results suggest that partners of OPC patients (oropharyngeal squamous cell cancer patients) have a higher oral HPV prevalence than that found in the general population.” (1) The study was published in the medical journal, Infectious Agents and Cancer. Dr. Tsao is from The University of Texas MD Anderson Cancer Center in Houston, Texas.

Research shows that worldwide rates of oral HPV infection and resulting head and neck cancers are rising. (2) Dr. Forte and colleagues wrote in a study that “recently, human papillomavirus (HPV) infection has been causally associated with a subset of head and neck cancers, particularly oropharyngeal cancer.” (3) Dr. Forte and colleagues are from the Canadian Partnership Against Cancer.

The CBCD therefore recommends that anyone who suspects that they have an oral HPV infection talk to their doctors about Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was shown to safely and effectively reduce symptoms associated with HPV in two separate post-marketing clinical studies that followed FDA guidelines.

Click to learn more about HPV symptoms.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (4) The study authors also wrote that “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (4)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Note: Novirin has the same formula as Gene-Eden-VIR. However, it contains higher quality and more expensive ingredients.

The CDC notes that “some studies suggest that oral HPV may be passed on during oral sex (from mouth-to-genital or mouth-to-anus contact) or open-mouthed (“French”) kissing, others have not. The likelihood of getting HPV from kissing or having oral sex with someone who has HPV is not known. We do know that partners who have been together a long time tend to share genital HPV-meaning they both may have it.” (5) Additionally, the CDC says that “there is no FDA-approved test to diagnose HPV in the mouth or throat. Medical and dental organizations do not recommend screening for oral HPV.” Thus, there is no way to know for sure if a person has an oral HPV infection unless the person develops genital warts in the mouth.

Are there treatments available against the HPV?

“There are no drugs approved against the HPV. Current treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission.” (4) In contrast, Novirin and Gene-Eden-VIR were designed to target the latent HPV.

“We recommend that individuals infected with the HPV virus take Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

Individuals interested in viewing published studies on the formula of Novirin and Gene-Eden-VIR can go here:

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.U-s9ouOSz90

and

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.U-s9w-OSz90

All orders of Gene-Eden-VIR and Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Chen, Hsin-Hung, I-Ching Lin, Hsuan-Ju Chen, Su-Yin Yeh, and Chia-Hung Kao. "Association of Herpes Zoster and Type 1 Diabetes Mellitus." PLoS One (May 12, 2016). Pubmed. Web. 16 May 2016.

(2) Forte T1, Niu J, Lockwood GA, Bryant HE. "Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009." Cancer Causes Control. 2012 Aug;23(8):1343-8.
http://www.ncbi.nlm.nih.gov/pubmed/22718355

(3) Percinoto AC, Danelon M, Crivelini MM, Cunha RF, Percinoto C1. Condyloma acuminata in the tongue and palate of a sexually abused child: a case report. BMC Res Notes. 2014 Jul 23;7:467.
ncbi.nlm.nih.gov/pubmed/25053204

(4) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8http://dx.doi.org/10.4236/pp.2013.46A001

(5) CDC.org - Human papillomavirus (HPV) and Oropharyngeal Cancer - Fact Sheet. Last Updated on November 22, 2013.
cdc.gov/std/hpv/stdfact-hpvandoropharyngealcancer.htm

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.